Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial (SEPSIS-ACT). A Double-blind, Randomised, Placebo-controlled, Phase 2b/3 Adaptive Clinical Trial Investigating the Efficacy and Safety of Selepressin as Treatment for Patients with Vasopressor-dependent Septic Shock. An international multicenter study by Feering Pharmaceuticals, Clinical Phase 2b/3. 2015-17. (Principal Investigator)

Projekt: Typer af projekter

Vis graf over relationer
StatusAfsluttet
Periode01/07/201531/12/2017

ID: 54756091